Main Session
Sep
27
PQA 02 - PQA 02: Pediatric Cancer, Sarcoma and Cutaneous Tumors, Medical Education & Professional Development, and Health Services Research
2391 - Phase I Study of Neoadjuvant Atezolizumab plus Concurrent SBRT in Borderline Resectable or Unresectable Cutaneous Squamous Cell Carcinoma: Preliminary Safety and Efficacy Results
Presenter(s)
Kim Vo, DO, MS - City of Hope Comprehensive Cancer Center, Duarte, CA